SG63528A1 - Cycloalkano-indole and -azaindole derivatives - Google Patents

Cycloalkano-indole and -azaindole derivatives

Info

Publication number: SG63528A1
Authority: SG; Singapore
Prior art keywords: opt; substd; alkyl; phenyl; alkoxy
Prior art date: 1994-10-04

Application number

SG1995001478A

Other languages

English (en)

Inventor

Anke Domdey-Bette

Dirk Denzer

Hillmar Bischoff

Beuck Martin

Connell Richard

Grutzmann Rudi

Goldmann Siefried

Wohlfeil Stefan

Muller Ulrich

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-04

Filing date

1995-10-03

Publication date

1999-03-30

1995-10-03 Application filed by Bayer Ag filed Critical Bayer Ag

1999-03-30 Publication of SG63528A1 publication Critical patent/SG63528A1/en

Links

125000000217 alkyl group Chemical group 0.000 abstract 9
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 6
125000003545 alkoxy group Chemical group 0.000 abstract 5
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 4
125000002252 acyl group Chemical group 0.000 abstract 3
125000003342 alkenyl group Chemical group 0.000 abstract 3
125000005843 halogen group Chemical group 0.000 abstract 3
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
150000001925 cycloalkenes Chemical class 0.000 abstract 1
125000005842 heteroatom Chemical group 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
125000004076 pyridyl group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/02—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with only hydrogen, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)

SG1995001478A 1994-10-04 1995-10-03 Cycloalkano-indole and -azaindole derivatives SG63528A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4435477A DE4435477A1 (de)	1994-10-04	1994-10-04	Cycloalkano-indol- und -azaindol-derivate

Publications (1)

Publication Number	Publication Date
SG63528A1 true SG63528A1 (en)	1999-03-30

Family

ID=6529939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG1995001478A SG63528A1 (en)	1994-10-04	1995-10-03	Cycloalkano-indole and -azaindole derivatives

Country Status (35)

Country	Link
US (6)	US5684014A (cs)
EP (1)	EP0705831B1 (cs)
JP (1)	JP3901234B2 (cs)
KR (1)	KR100355986B1 (cs)
CN (2)	CN1183111C (cs)
AT (1)	ATE255580T1 (cs)
AU (1)	AU700609B2 (cs)
CA (1)	CA2159546C (cs)
CZ (1)	CZ291348B6 (cs)
DE (2)	DE4435477A1 (cs)
DK (1)	DK0705831T3 (cs)
DZ (1)	DZ1934A1 (cs)
EE (1)	EE03527B1 (cs)
ES (1)	ES2211890T3 (cs)
FI (2)	FI113048B (cs)
HN (1)	HN1995009160A (cs)
HR (1)	HRP950505B1 (cs)
HU (1)	HU225052B1 (cs)
IL (3)	IL115493A (cs)
MA (1)	MA23683A1 (cs)
MY (1)	MY117282A (cs)
NO (1)	NO305365B1 (cs)
NZ (1)	NZ280130A (cs)
PH (1)	PH31400A (cs)
PL (1)	PL183154B1 (cs)
PT (1)	PT705831E (cs)
RU (1)	RU2157803C2 (cs)
SG (1)	SG63528A1 (cs)
SI (1)	SI0705831T1 (cs)
SK (1)	SK284260B6 (cs)
SV (1)	SV1995000062A (cs)
TN (1)	TNSN95098A1 (cs)
TW (1)	TW448175B (cs)
UA (1)	UA44700C2 (cs)
ZA (1)	ZA958297B (cs)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4435477A1 (de) *	1994-10-04	1996-04-11	Bayer Ag	Cycloalkano-indol- und -azaindol-derivate
DE19525028A1 (de) *	1995-07-10	1997-01-16	Bayer Ag	Amide und Sulfonamide von heterocyclisch substituierten Benzylaminen
US6774236B1 (en)	1996-04-04	2004-08-10	Bayer Aktiengesellschaft	Process for the preparation of enantiomerically pure cycloalkano-indol -and azaindol -and pyrimido [1,2A]indolcarbocyclic acids and their activated derivatives
DE19613549A1 (de) *	1996-04-04	1997-10-09	Bayer Ag	Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate
EP0802192A1 (de) *	1996-04-17	1997-10-22	Bayer Ag	Heterocyclisch-substituierte Phenylglycinolamide mit antiatherosklerotischer Wirkung und Verfahren zu ihrer Herstellung
DE19619950A1 (de)	1996-04-17	1997-10-23	Bayer Ag	Heterocyclisch-substituierte Phenylglycinolamide
DE19615119A1 (de) *	1996-04-17	1997-10-23	Bayer Ag	Neue Arylessigsäureamide
DE19615265A1 (de) *	1996-04-18	1997-12-04	Bayer Ag	Neue Pyridazino-, Pyrimido-, Pyrazino- und Triazino-indole
ID27812A (id) *	1998-05-01	2001-04-26	Lilly Co Eli	ESTER PENGHAMBAT sPLA2
DE69914563T2 (de)	1998-10-30	2004-12-16	Eli Lilly And Co., Indianapolis	Azaindol derivate und ihre Verwendung als antithrombotische Wirkstoffe
AU4616200A (en) *	1999-05-25	2000-12-12	Yamanouchi Pharmaceutical Co., Ltd.	Hydrazide derivatives
DE19929065A1 (de) *	1999-06-25	2000-12-28	Bayer Ag	Kombination von MTP-Inhibitoren und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
DE19934610A1 (de) *	1999-07-23	2001-01-25	Bayer Ag	Schnellfreisetzende Extrudate und Verfahren zu ihrer Herstellung sowie daraus erhältliche Zubereitungen
CA2402549A1 (en) *	2000-03-15	2001-09-20	Aventis Pharma Deutschland Gmbh	Substituted beta-carbolines
EP1134221A1 (en) *	2000-03-15	2001-09-19	Aventis Pharma Deutschland GmbH	Substituted beta-carbolines as lkB kinase inhibitors
AU2001244635A1 (en) *	2000-03-30	2001-10-15	Yamanouchi Pharmaceutical Co..Ltd.	Hydrazide derivatives
DE10030375A1 (de) *	2000-06-21	2002-01-03	Bayer Ag	Verwendung von MTP-Inhibitoren zur Senkung von ppTRL
EP1363638A4 (en) *	2001-01-31	2010-01-06	Lundbeck & Co As H	USE OF GAL3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF DEPRESSION AND / OR ANXIETIES AND USEFUL CONNECTIONS FOR SUCH PROCEDURES
GB0115109D0 (en) *	2001-06-21	2001-08-15	Aventis Pharma Ltd	Chemical compounds
ZA200502496B (en) *	2002-02-28	2005-10-12	Japan Tobacco Inc	Ester compound and medicinal use thereof.
JPWO2003101983A1 (ja) *	2002-05-31	2005-09-29	アステラス製薬株式会社	テトラヒドロピラン誘導体
RU2342362C2 (ru) *	2002-11-26	2008-12-27	Шэньчжэнь Чипскрин Байосайенсиз Лтд.	Замещенные производные арилалкановой кислоты как пан агонисты рапп с высокой антигипергликемической и антигиперлипидемической активностью
WO2004063156A1 (en) *	2003-01-08	2004-07-29	Biovitrum Ab	Novel indole derivates as fabp-4 inhibitors
WO2005051382A1 (ja) *	2003-11-28	2005-06-09	Astellas Pharma Inc.	脂質低下作用増強剤
US7649002B2 (en)	2004-02-04	2010-01-19	Pfizer Inc	(3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
PT1725234E (pt)	2004-03-05	2013-03-04	Univ Pennsylvania	Métodos com efeitos secundários reduzidos para tratamento de patologias ou doenças associadas a hiperlipidemia e hipercolesterolemia
US7262318B2 (en) *	2004-03-10	2007-08-28	Pfizer, Inc.	Substituted heteroaryl- and phenylsulfamoyl compounds
EP1737460A2 (en) *	2004-04-09	2007-01-03	Janssen Pharmaceutica N.V.	Intermittent dosing regimen for the treatment of overweight with mtp-inhibitors
US20050288340A1 (en) *	2004-06-29	2005-12-29	Pfizer Inc	Substituted heteroaryl- and phenylsulfamoyl compounds
US20060030623A1 (en) *	2004-07-16	2006-02-09	Noboru Furukawa	Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
FR2873694B1 (fr) *	2004-07-27	2006-12-08	Merck Sante Soc Par Actions Si	Nouveaux aza-indoles inhibiteurs de la mtp et apob
US8101774B2 (en) *	2004-10-18	2012-01-24	Japan Tobacco Inc.	Ester derivatives and medicinal use thereof
KR20070072888A (ko) *	2004-10-25	2007-07-06	니뽄 다바코 산교 가부시키가이샤	용해성 및 안정성이 개선된 고형 제제 및 그의 제조 방법
PA8660701A1 (es)	2005-02-04	2006-09-22	Pfizer Prod Inc	Agonistas de pyy y sus usos
WO2006129193A2 (en) *	2005-05-27	2006-12-07	Pfizer Products Inc.	Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss
CA2617654A1 (en) *	2005-08-04	2007-02-08	Pfizer Limited	Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
EP1951220A2 (en) *	2005-10-18	2008-08-06	Aegerion Pharmaceuticals	Compositions for lowering serum cholesterol and/or triglycerides
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
US7888376B2 (en)	2005-11-23	2011-02-15	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
AU2007219236B2 (en) *	2006-02-23	2012-06-21	Pfizer Limited	Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
US8383660B2 (en)	2006-03-10	2013-02-26	Pfizer Inc.	Dibenzyl amine compounds and derivatives
JP2009537505A (ja) *	2006-05-18	2009-10-29	バイエル・ヘルスケア・アクチェンゲゼルシャフト	インプリタピドを含む薬学的組成物およびこの薬学的組成物の使用方法
CN101583593A (zh)	2006-11-13	2009-11-18	辉瑞产品公司	二芳基、二吡啶基和芳基-吡啶基衍生物及其用途
ATE547394T1 (de)	2006-12-01	2012-03-15	Bristol Myers Squibb Co	N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
JP2010513534A (ja) *	2006-12-21	2010-04-30	エージェリオンファーマシューティカルズ，インコーポレイテッド	Ｍｔｐインヒビターおよびコレステロール吸収インヒビターを含む組み合わせを用いて肥満症を処置する方法
RU2338745C1 (ru) *	2007-03-21	2008-11-20	Андрей Александрович Иващенко	ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
WO2008124384A2 (en) *	2007-04-03	2008-10-16	Aegerion Pharmaceuticals, Inc.	Combinations of mtp inhibitors with cholesterol absorption inhibitors or interferon for treating hepatitis c
JP5530438B2 (ja) *	2008-08-06	2014-06-25	ファイザー・リミテッド	Ｍｃ４作動薬としてのジアゼピンおよびジアゾカン化合物
SI2968284T1 (sl)	2013-03-14	2021-08-31	Osteoqc Inc.	Alkil-amin harmin derivati za pospeševanje rasti kosti
CA2960101C (en) *	2014-09-05	2024-05-21	Allosteros Therapeutics, Inc.	Substituted carboline derivative and compositions thereof useful as camkii inhibitors
CN108218862B (zh) *	2018-02-07	2020-06-23	贵州医科大学	α-卡波林类衍生物在制备抗心肌缺氧复氧损伤药物中的应用
CN110467560B (zh) *	2018-05-09	2025-11-25	深圳微芯生物科技股份有限公司	一种苯基氨基丙酸钠衍生物、其制备方法和应用
EP3836923B1 (en)	2018-08-14	2024-10-16	OssiFi Therapeutics LLC	Pyrrolo - dipyridine compounds for the treatment of bone loss
JP7695496B2 (ja)	2018-08-14	2025-06-19	オシフィセラピューティクスリミティドライアビリティカンパニー	フルオロβ－カルボリン化合物
BR112023000808A2 (pt)	2020-07-29	2023-02-07	Amryt Pharmaceuticals Inc	Lomitapida para uso em métodos para tratar hiperlipidemia e hipercolesterolemia em pacientes pediátricos

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH501623A (de) *	1967-12-18	1971-01-15	Ruetgerswerke Ag	Verfahren zur Herstellung von 2-Chlorpyridin und seinen Derivaten
US4808608A (en) *	1986-01-23	1989-02-28	Merck & Co., Inc.	Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use
IL81325A (en) *	1986-01-23	1990-11-29	Merck Frosst Canada Inc	Tetrahydrocarbazole 1-alkanoic acids and pharmaceutical compositions containing them
US4940719A (en) *	1986-03-27	1990-07-10	Merck Frosst Canada, Inc.	Tetrahydrocarbazole esters, pharmaceutical compositions and use
CA1326030C (en) *	1987-07-21	1994-01-11	John W. Gillard	Cyclohept[b]indolealkanoic acids
US4775680A (en) *	1987-07-21	1988-10-04	Merck & Co., Inc.	Cyclohept[b]indolealkanoic acids, pharmaceutical compositions and use
GB9101375D0 (en) *	1991-01-22	1991-03-06	Erba Carlo Spa	N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole
DE4112533A1 (de) *	1991-04-17	1992-10-22	Bayer Ag	Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren
DE4200954A1 (de)	1991-04-26	1992-10-29	Bayer Ag	Heterocyclisch substituierte phenylessigsaeurederivate
DE4308788A1 (de) *	1993-03-18	1994-09-22	Bayer Ag	Hetero-tricyclisch-substituierte Phenyl-cyclohexan-carbonsäurederivate
DE4435477A1 (de) *	1994-10-04	1996-04-11	Bayer Ag	Cycloalkano-indol- und -azaindol-derivate
DE19613549A1 (de)	1996-04-04	1997-10-09	Bayer Ag	Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate
DE19615119A1 (de) *	1996-04-17	1997-10-23	Bayer Ag	Neue Arylessigsäureamide

1994
- 1994-10-04 DE DE4435477A patent/DE4435477A1/de not_active Withdrawn
1995
- 1995-02-07 HN HN1995009160A patent/HN1995009160A/es unknown
- 1995-09-21 EP EP95114877A patent/EP0705831B1/de not_active Expired - Lifetime
- 1995-09-21 PT PT95114877T patent/PT705831E/pt unknown
- 1995-09-21 DK DK95114877T patent/DK0705831T3/da active
- 1995-09-21 ES ES95114877T patent/ES2211890T3/es not_active Expired - Lifetime
- 1995-09-21 AT AT95114877T patent/ATE255580T1/de not_active IP Right Cessation
- 1995-09-21 DE DE59510839T patent/DE59510839D1/de not_active Expired - Lifetime
- 1995-09-21 SI SI9530693T patent/SI0705831T1/xx unknown
- 1995-09-27 AU AU32920/95A patent/AU700609B2/en not_active Ceased
- 1995-09-27 HR HR950505A patent/HRP950505B1/xx not_active IP Right Cessation
- 1995-09-28 US US08/535,698 patent/US5684014A/en not_active Expired - Lifetime
- 1995-09-29 NZ NZ280130A patent/NZ280130A/en not_active IP Right Cessation
- 1995-09-29 CA CA2159546A patent/CA2159546C/en not_active Expired - Fee Related
- 1995-10-02 KR KR1019950033651A patent/KR100355986B1/ko not_active Expired - Fee Related
- 1995-10-02 FI FI954681A patent/FI113048B/fi active
- 1995-10-02 DZ DZ950116A patent/DZ1934A1/fr active
- 1995-10-02 TW TW084110247A patent/TW448175B/zh active
- 1995-10-02 MA MA24027A patent/MA23683A1/fr unknown
- 1995-10-02 IL IL11549395A patent/IL115493A/xx not_active IP Right Cessation
- 1995-10-02 IL IL12964195A patent/IL129641A/xx not_active IP Right Cessation
- 1995-10-02 IL IL12964199A patent/IL129641A0/xx unknown
- 1995-10-02 TN TNTNSN95098A patent/TNSN95098A1/fr unknown
- 1995-10-03 PH PH51415A patent/PH31400A/en unknown
- 1995-10-03 ZA ZA958297A patent/ZA958297B/xx unknown
- 1995-10-03 CZ CZ19952567A patent/CZ291348B6/cs not_active IP Right Cessation
- 1995-10-03 UA UA95104372A patent/UA44700C2/uk unknown
- 1995-10-03 SG SG1995001478A patent/SG63528A1/en unknown
- 1995-10-03 NO NO953930A patent/NO305365B1/no not_active IP Right Cessation
- 1995-10-03 HU HU9502891A patent/HU225052B1/hu not_active IP Right Cessation
- 1995-10-03 SK SK1239-95A patent/SK284260B6/sk not_active IP Right Cessation
- 1995-10-03 EE EE9500071A patent/EE03527B1/xx not_active IP Right Cessation
- 1995-10-03 JP JP27966495A patent/JP3901234B2/ja not_active Expired - Fee Related
- 1995-10-03 PL PL95310756A patent/PL183154B1/pl not_active IP Right Cessation
- 1995-10-03 RU RU95117070/04A patent/RU2157803C2/ru not_active IP Right Cessation
- 1995-10-04 CN CNB981260853A patent/CN1183111C/zh not_active Expired - Fee Related
- 1995-10-04 CN CN95117117A patent/CN1050605C/zh not_active Expired - Fee Related
- 1995-10-04 MY MYPI95002964A patent/MY117282A/en unknown
- 1995-10-04 SV SV1995000062A patent/SV1995000062A/es active IP Right Grant
1997
- 1997-07-03 US US08/887,781 patent/US6245775B1/en not_active Expired - Lifetime
1999
- 1999-05-17 US US09/313,035 patent/US6265431B1/en not_active Expired - Lifetime
2000
- 2000-12-08 FI FI20002693A patent/FI108791B/fi active
- 2000-12-11 US US09/734,955 patent/US20020147209A1/en not_active Abandoned
2001
- 2001-03-21 US US09/814,263 patent/US6479503B2/en not_active Expired - Lifetime
2002
- 2002-07-18 US US10/198,315 patent/US6858622B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IL129641A (en)	2000-08-31
US6479503B2 (en)	2002-11-12
UA44700C2 (uk)	2002-03-15
TNSN95098A1 (fr)	1996-02-06
US20020147209A1 (en)	2002-10-10
EE9500071A (et)	1996-04-15
US20030149073A1 (en)	2003-08-07
IL129641A0 (en)	2000-02-29
HU9502891D0 (en)	1995-11-28
EP0705831B1 (de)	2003-12-03
AU700609B2 (en)	1999-01-07
HN1995009160A (es)	2000-04-24
KR960014126A (ko)	1996-05-22
EE03527B1 (et)	2001-10-15
HUT73240A (en)	1996-07-29
ES2211890T3 (es)	2004-07-16
CA2159546A1 (en)	1996-04-05
PT705831E (pt)	2004-04-30
ATE255580T1 (de)	2003-12-15
US20020055635A1 (en)	2002-05-09
PL183154B1 (pl)	2002-05-31
US6858622B2 (en)	2005-02-22
RU2157803C2 (ru)	2000-10-20
FI113048B (fi)	2004-02-27
NO953930D0 (no)	1995-10-03
EP0705831A2 (de)	1996-04-10
IL115493A0 (en)	1996-01-19
PH31400A (en)	1998-10-29
JPH08225526A (ja)	1996-09-03
DK0705831T3 (da)	2004-04-05
DE4435477A1 (de)	1996-04-11
AU3292095A (en)	1996-04-18
FI108791B (fi)	2002-03-28
MY117282A (en)	2004-06-30
HRP950505A2 (en)	1997-08-31
MA23683A1 (fr)	1996-07-01
IL115493A (en)	1999-10-28
SI0705831T1 (en)	2004-02-29
ZA958297B (en)	1996-05-06
CN1130631A (zh)	1996-09-11
US6245775B1 (en)	2001-06-12
CA2159546C (en)	2010-12-14
EP0705831A3 (de)	1997-01-22
CZ256795A3 (en)	1996-04-17
JP3901234B2 (ja)	2007-04-04
US6265431B1 (en)	2001-07-24
FI954681A7 (fi)	1996-04-05
HU225052B1 (en)	2006-05-29
CN1183111C (zh)	2005-01-05
SV1995000062A (es)	1996-07-10
SK284260B6 (sk)	2004-12-01
NO305365B1 (no)	1999-05-18
SK123995A3 (en)	1996-06-05
CN1224715A (zh)	1999-08-04
HRP950505B1 (en)	2002-04-30
DZ1934A1 (fr)	2002-02-17
DE59510839D1 (de)	2004-01-15
US5684014A (en)	1997-11-04
HK1005139A1 (en)	1998-12-24
KR100355986B1 (ko)	2003-01-06
NZ280130A (en)	1996-05-28
FI20002693L (fi)	2000-12-08
TW448175B (en)	2001-08-01
CZ291348B6 (cs)	2003-02-12
FI954681A0 (fi)	1995-10-02
CN1050605C (zh)	2000-03-22
PL310756A1 (en)	1996-04-15
NO953930L (no)	1996-04-09

Publication	Publication Date	Title
ZA958297B (en)	1996-05-06	Cycloalkano-indole and -azaindole derivatives
PL310460A1 (en)	1996-03-18	Novel derivatives of imidazopyridine, method of obtaining them and drugs containing such derivatives
AU3992797A (en)	1998-04-09	New substituted biphenyl or phenylpyridine compounds, a process for their preparation and pharmaceutical compositions containing them
DE3881468D1 (de)	1993-07-08	Heterocyclisch substituierte azole und azine, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider wirkung.
AU2819992A (en)	1993-05-13	Hiv protease inhibitors useful for the treatment of aids
HU9600914D0 (en)	1996-05-28	4-indolylpiperazinyl derivatives
GR3035371T3 (en)	2001-05-31	Benzyloxy-substituted phenylglycinolamides as pharmaceutical agents
NO964500D0 (no)	1996-10-23	Farmasöytiske preparater inneholdende et beta-laktamase-inhiberende penem i kombinasjon med et beta-laktam antibiotikum og deres anvendelse ved behandling av bakterielle infeksjoner
GR3032394T3 (en)	2000-05-31	Use of 1,2-bridged 1,4-dihydropyridines as selective potassium channel modulators
IL119054A (en)	2000-10-31	Substituted 4H-pyrans their preparation and pharmaceutical compositions containing them
AU3748697A (en)	1998-03-19	2-cyano-3, 5-dihydroxyhex-2-enecarboxamide derivatives